A challenging differential diagnosis for Pelizaeus-Merzbacher Syndrome: a literature review
DOI:
https://doi.org/10.33448/rsd-v11i13.35315Keywords:
Child; Neurodegenerative disease; Leukodystrophies; Pelizaeus-Merzbacher.Abstract
In children, white matter disorders are traditionally divided into two main categories: leukodystrophy and leukoencephalopathies. The former are the result of inherited enzyme deficiency that causes abnormal formation, renewal of myelin or destruction. In contrast, leukoencephalopathies involve the destruction of intrinsically normal myelin, with the demyelination mechanism being primarily divided into lysosomal and peroxisomal. In this context, Pelizaeus-Merzbacher Syndrome (PMD) is an X-linked leukodystrophy, characterized by delayed neuropsychomotor development in children. It is a rare disease, predominantly in males, compromising the development and/or maintenance of myelin in the Central Nervous System (CNS). Therefore, the present study aimed to gather scientific articles through a narrative review on Pelizaeus Merzbacher Disease, addressing its classification, pathophysiology, signs and symptoms and the challenges to reach its diagnosis. In this way, this study brings new updates on the disease and helps in directing a differential diagnosis, as well as seeking a better intervention for patients with Pelizaeus-Merzbacher Syndrome.
References
Ashrafi, M. R., Amanat, M., Garshasbi, M., Kameli, R., Nilipour, Y., Heidari, M., ... & Tavasoli, A. R. (2020). An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies. Expert Review of Neurotherapeutics, 20(1), 65-84.
Biancheri, R., Grossi, S., Regis, S., Rossi, A., Corsolini, F., Rossi, D. P., ... & Filocamo, M. (2014). Further genotype–phenotype correlation emerging from two families with PLP1 exon 4 skipping. Clinical Genetics, 85(3), 267-272.
Bonkowsky, J. L., Nelson, C., Kingston, J. L., Filloux, F. M., Mundorff, M. B., & Srivastava, R. (2010). The burden of inherited leukodystrophies in children. Neurology, 75(8), 718-725.
Brenner, M., Johnson, A. B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. E., & Messing, A. (2001). Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature genetics, 27(1), 117-120.
Brum, C. D., Zuge, S. S., Rangel, R. F., Freitas, H. M. B., & Pieszak, G. M. (2015). Revisão narrativa da literatura: aspectos conceituais e metodológicos na construção do conhecimento da enfermagem. Metodologias da pesquisa para a enfermagem e saúde: da teoria à prática. Porto Alegre: Moriá.
Cordeiro, A. M., Oliveira, G. M. D., Rentería, J. M., & Guimarães, C. A. (2007). Revisão sistemática: uma revisão narrativa. Revista do Colégio Brasileiro de Cirurgiões, 34, 428-431.
Costello, D. J., Eichler, A. F., & Eichler, F. S. (2009). Leukodystrophies: classification, diagnosis, and treatment. The neurologist, 15(6), 319-328.
da Costa Anciães, J., de Lima, F. A., Borges, J. B. C., & de Faria, T. C. C. (2020). Síndrome de pelizaeus-merzbacher–relato de caso e classificação no modelo biopsicossocial proposto pela classificação internacional de funcionalidade, incapacidade e saúde (CIF). Brazilian Journal of Development, 6(7), 43501-43519.
Dhaunchak, A. S., Colman, D. R., & Nave, K. A. (2011). Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus–Merzbacher disease. Journal of Neuroscience, 31(42), 14961-14971.
Fancy, S. P., Chan, J. R., Baranzini, S. E., Franklin, R. J., & Rowitch, D. H. (2011). Myelin regeneration: a recapitulation of development?. Annual review of neuroscience, 34, 21-43.
Gowda, V. K., Bharathi, N. K., Bettaiah, J., Bhat, M., & Shivappa, S. K. (2021). Canavan Disease: Clinical and laboratory profile from Southern part of India. Annals of Indian Academy of Neurology, 24(3), 347.
Gruenenfelder, F. I., McLaughlin, M., Griffiths, I. R., Garbern, J., Thomson, G., Kuzman, P., ... & Edgar, J. M. (2020). Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease. Brain, 143(5), 1383-1399.
Hartley, M. D., Kirkemo, L. L., Banerji, T., & Scanlan, T. S. (2017). A thyroid hormone–based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy. Endocrinology, 158(5), 1328-1338.
Hobson, G. M., & Garbern, J. Y. (2012, February). Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. In Seminars in neurology (Vol. 32, No. 01, pp. 062-067). Thieme Medical Publishers.
Hudson, L. D. (2003). Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene. Journal of child neurology, 18(9), 616-624.
Hurst, S., Garbern, J., Trepanier, A., & Gow, A. (2006). Quantifying the carrier female phenotype in Pelizaeus-Merzbacher disease. Genetics in Medicine, 8(6), 371-378.
Inoue, K. (2019). Pelizaeus-Merzbacher disease: Molecular and cellular pathologies and associated phenotypes. Myelin, 201-216.
Jiang, M. Y., Cai, Y. N., Liang, C. L., Peng, M. Z., Sheng, H. Y., Fan, L. P., ... & Liu, L. (2015). Clinical, biochemical, neuroimaging and molecular findings of X-linked Adrenoleukodystrophy patients in South China. Metabolic brain disease, 30(6), 1439-1444.
Keogh, M. J., Jaiser, S. R., Steele, H. E., Horvath, R., Chinnery, P. F., & Baker, M. R. (2017). PLP1 mutations and central demyelination: Evidence from electrophysiologic phenotyping in female manifesting carriers. Neurology: Clinical Practice, 7(5), 451-454.
Kevelam, S. H., Steenweg, M. E., Srivastava, S., Helman, G., Naidu, S., Schiffmann, R., Blaser, S., Vanderver, A., Wolf, N. I., & van der Knaap, M. S. (2016). Update on Leukodystrophies: A Historical Perspective and Adapted Definition. Neuropediatrics, 47(6), 349–354.
Lossos, A., Elazar, N., Lerer, I., Schueler-Furman, O., Fellig, Y., Glick, B., ... & Peles, E. (2015). Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder. Brain, 138(9), 2521-2536.
Magen, D., Georgopoulos, C., Bross, P., Ang, D., Segev, Y., Goldsher, D., ... & Mandel, H. (2008). Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. The American Journal of Human Genetics, 83(1), 30-42.
Meo, S. A. (2021). Environmental Pollution and the Brain. CRC Press.
Osório, M. J., & Goldman, S. A. (2018). Neurogenetics of Pelizaeus–Merzbacher disease. Handbook of clinical neurology, 148, 701-722.
Pediatric demyelinating diseases: a review. Child Neuropsychology, 24(5), 575-597.
Pouwels, P. J., Vanderver, A., Bernard, G., Wolf, N. I., Dreha‐Kulczewksi, S. F., Deoni, S. C., ... & Barkovich, A. J. (2014). Hypomyelinating leukodystrophies: translational research progress and prospects. Annals of neurology, 76(1), 5-19.
Rosenberg, J. B., Kaminsky, S. M., Aubourg, P., Crystal, R. G., & Sondhi, D. (2016). Gene therapy for metachromatic leukodystrophy. Journal of neuroscience research, 94(11), 1169–1179.
Scala, M., Traverso, M., Capra, V., Vari, M. S., Severino, M., Grossi, S., ... & Minetti, C. (2019). Pelizaeus–Merzbacher disease due to PLP1 frameshift mutation in a female with nonrandom skewed X-chromosome inactivation. Neuropediatrics, 50(04), 268-270.
Scheffer, I. E., Baraitser, M., Wilson, J., Harding, B., Kendall, B., & Brett, E. M. (1991). Pelizaeus-Merzbacher disease: classical or connatal?. Neuropediatrics, 22(02), 71-78.
Singh, R., & Samanta, D. (2021). Pelizaeus-Merzbacher Disease. In StatPearls [Internet]. StatPearls Publishing.
Snaidero, N., Möbius, W., Czopka, T., Hekking, L. H., Mathisen, C., Verkleij, D., ... & Simons, M. (2014). Myelin membrane wrapping of CNS axons by PI (3, 4, 5) P3-dependent polarized growth at the inner tongue. Cell, 156(1-2), 277-290.
Stellingwerff, M. D., Al-Saady, M. L., Van de Brug, T., Barkhof, F., Pouwels, P. J., & Van der Knaap, M. S. (2021). MRI natural history of the leukodystrophy vanishing white matter. Radiology.
Uhlenberg, B., Schuelke, M., Rüschendorf, F., Ruf, N., Kaindl, A. M., Henneke, M., Thiele, H., Stoltenburg-Didinger, G., Aksu, F., Topaloğlu, H., Nürnberg, P., Hübner, C., Weschke, B., & Gärtner, J. (2004). Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. American journal of human genetics, 75(2), 251–260.
Vanderver, A., Prus M., Tonduti, D., Mochel, F., Hussey, H. M., Helman, G., ... & Glia Consortium. (2015). Case definition and classification of leukodystrophies and leukoencephalopathies. Molecular genetics and metabolism, 114(4), 494-500.
Wenger, D. A., Luzi, P., & amp; Rafi, M. A. (2021). Advances in the Diagnosis and Treatment of Krabbe Disease. International Journal of Neonatal Screening, 7(3), 57.
Wibom, R., Lasorsa, F. M., Töhönen, V., Barbaro, M., Sterky, F. H., Kucinski, T., ... & Wedell, A. (2009). AGC1 deficiency associated with global cerebral hypomyelination. New England Journal of Medicine, 361(5), 489-495.
Wiesinger, C., Eichler, F. S., & Berger, J. (2015). The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. The application of clinical genetics, 8, 109.
Wishnew, J., Page, K., Wood, S., Galvin, L., Provenzale, J., Escolar, M., ... & Kurtzberg, J. (2014). Umbilical cord blood transplantation to treat Pelizaeus-Merzbacher Disease in 2 young boys. Pediatrics, 134(5), e1451-e1457.
Wolf, N. I., & van der Knaap, M. S. (2009). AGC1 deficiency and cerebral hypomyelination. New England Journal of Medicine, 361(20), 1997-1998.
Wolf, N. I., Van Spaendonk, R. M., Hobson, G. M., & Kamholz, J. (2019). Plp1 disorders.
Wolpert, S. M., Anderson, M. L., & Kaye, E. M. (1992). Metabolic and degenerative disorders. MRI in pediatric neruoradiology. Mosby Year Book, St Louis.
Woodward, K. J. (2008). The molecular and cellular defects underlying Pelizaeus–Merzbacher disease. Expert reviews in molecular medicine, 10.
Woodward, K., Kirtland, K., Dlouhy, S., Raskind, W., Bird, T., Malcolm, S., & Abeliovich, D. (2000). X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations. European Journal of Human Genetics, 8(6), 449-454.
Yoshida, T., Sasaki, M., Yoshida, M., Namekawa, M., Okamoto, Y., Tsujino, S., ... & Nakagawa, M. (2011). Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. Journal of neurology, 258(11), 1998-2008.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ericks Domiciano Borges; Nathan Colombo Alves; Érico Torrieri; Karen Cristina Froio; Priscilla Aparecida Tartari Pereira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
